Wealth Enhancement Advisory Services LLC increased its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 217.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,584 shares of the company's stock after buying an additional 5,878 shares during the quarter. Wealth Enhancement Advisory Services LLC's holdings in Molina Healthcare were worth $2,498,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the business. Wellington Management Group LLP lifted its position in shares of Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after buying an additional 181,073 shares during the last quarter. FMR LLC raised its position in Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after purchasing an additional 427,276 shares during the last quarter. Geode Capital Management LLC raised its position in Molina Healthcare by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after purchasing an additional 34,992 shares during the last quarter. Invesco Ltd. raised its position in Molina Healthcare by 28.5% in the fourth quarter. Invesco Ltd. now owns 1,327,021 shares of the company's stock valued at $386,229,000 after purchasing an additional 294,180 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Molina Healthcare by 15.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 688,245 shares of the company's stock valued at $200,307,000 after purchasing an additional 91,229 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several brokerages recently commented on MOH. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Stephens reiterated an "equal weight" rating and issued a $345.00 target price on shares of Molina Healthcare in a report on Thursday, February 6th. Baird R W cut Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Truist Financial increased their price target on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Finally, UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a report on Friday, February 7th. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Molina Healthcare currently has an average rating of "Hold" and a consensus target price of $364.54.
View Our Latest Analysis on MOH
Molina Healthcare Stock Performance
Shares of Molina Healthcare stock traded up $0.32 during trading hours on Thursday, hitting $292.93. 441,722 shares of the company's stock traded hands, compared to its average volume of 684,948. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23. The stock has a market capitalization of $15.88 billion, a price-to-earnings ratio of 14.34, a PEG ratio of 1.06 and a beta of 0.63. The company has a fifty day simple moving average of $321.15 and a 200-day simple moving average of $307.10. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. The firm had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. The business's revenue was up 12.2% compared to the same quarter last year. During the same period last year, the firm posted $5.73 EPS. Equities research analysts anticipate that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.
Insider Transactions at Molina Healthcare
In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the transaction, the chief executive officer now owns 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the sale, the director now owns 11,244 shares of the company's stock, valued at approximately $3,603,702. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Recommended Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.